Price Chart

Profile

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
URL https://www.ligand.com
Investor Relations URL https://investor.ligand.com/
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 27, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jul. 02, 2010

Profile

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
URL https://www.ligand.com
Investor Relations URL https://investor.ligand.com/
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 27, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jul. 02, 2010